1-20 of 89
Aspasia Stamatoullas
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase II Study of Single Agent Aspacytarabine (BST-236) in Adults Unfit for Intensive Chemotherapy with Relapsed or Refractory Acute Myeloid Leukemia (R/R AML) or Higher Risk Myelodysplastic Syndromes (R/R HR MDS)

Marie Anne Hospital, Thomas Cluzeau, Alice Garnier, Giovanni Marconi, Emmanuelle Tavernier, Sylvain Thepot, Aspasia Stamatoullas, Cristina Papayannidis, Sophie Park, Noemie Bigot, Lamya AIT SI Selmi, Fatiha Chermat, Sylvie Chevret, Pierre Fenaux
Journal: Blood
Blood (2023) 142 (Supplement 1): 2923.
https://doi.org/10.1182/blood-2023-185609
Published: 2023
Journal Articles

Efficacy and Safety of Luspatercept +/- Erythropoiesis-Stimulating Agent (ESA) in Patients with Myelodysplastic Syndromes with Ring Sideroblasts (MDS-RS): A French Multicenter Prospective Real-Life Registry

Thibault Comont, Maud D'Aveni, Laurence Schenone, Jose Miguel Torregrosa-Díaz, Lorea Aguinaga, Juan Pardo, Marie Sebert, Sorin Visanica, Clemence Santana, Lenaig Le Clech, Aspasia Stamatoullas, Sylvain Thepot, Etienne Daguindau, Guillaume Beziat, Teresa Botin, Sophie Dimicoli, Sophie Park, Etienne Paubelle, Bohrane Slama, Lise Willems, Houria Debarri, Emmanuel Gyan, Claire Calmettes, Odile Rauzy, Fatiha Chermat, Michaela Fontenay, Lionel Ades, Pierre Fenaux
Journal: Blood
Blood (2023) 142 (Supplement 1): 6471.
https://doi.org/10.1182/blood-2023-177787
Published: 2023
Journal Articles

Total Metabolic Tumor Volume and Tumor Dissemination Are Independent Prognostic Factors in Advanced Hodgkin Lymphoma

Salim Kanoun, Alina Berriolo-Riedinger, Anne Ségolène Cottereau, Veronique Edeline, Ilan Tal, Pauline Brice, Reda Bouabdallah, Herve Ghesquieres, Aspasia Stamatoullas-Bastard, Jehan Dupuis, Marc André, Thomas Gastinne, Julien Lazarovici, Samuel Griolet, Cedric Rossi, Michel Meignan, Rene-Olivier Casasnovas
Journal: Blood
Blood (2021) 138 (Supplement 1): 880.
https://doi.org/10.1182/blood-2021-147177
Published: 2021
Journal Articles

Long Term Follow-up and Combined Phase 2 Results of Eprenetapopt (APR-246) and Azacitidine (AZA) in Patients with TP53 mutant Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia (AML)

David A. Sallman, Rami S. Komrokji, Amy E. DeZern, Marie Sebert, Guillermo Garcia-Manero, Ramy Rahmé, David P. Steensma, Jacqueline Lehmann che, Gail J. Roboz, Isabelle Madelaine, Mikkael A. Sekeres, Pierre Peterlin, Kendra Sweet, Odile Beyne Rauzy, Andrew T. Kuykendall, Christian Recher, Amy F McLemore, Aspasia Stamatoullas, Ling Zhang, Lise Willems, Qianxing Mo, Emmanuel Raffoux, Lisa Nardelli, Celine Berthon, Najla Al Ali, Bruno Quesnel, Eric Padron, Greg Korbel, Eyal C. Attar, Hagop Kantarjian, Alan F. List, Lionel Ades, Jeffrey E. Lancet, Pierre Fenaux, Thomas Cluzeau
Journal: Blood
Blood (2021) 138 (Supplement 1): 246.
https://doi.org/10.1182/blood-2021-153286
Published: 2021
Journal Articles

Stage IIb High Risk Hodgkin Lymphoma Treated in the H10 and AHL2011 Trials: Similar Efficacy of Both Strategies and Prognostic Impact of Baseline Tmtv and PET2 Response

Cédric Rossi, MD PhD, Marc André, Clémentine Joubert, PhD, Catherine Fortpied, Pauline Brice, Bénédicte Deau-Fisher, MD, Herve Ghesquieres, MD PhD, Luc Mathieu Fornecker, MD PhD, Anne-Claire Gac, MD, Julien Lazarovici, Aspasia Stamatoullas, MD, John Raemakers, Massimo Federico, MD, Marie Maerevoet, MD, Sarah Bailly, MD, Salim Kanoun, MD, Michel Meignan, Anne Ségolène Cottereau, Rene-Olivier Casasnovas, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 128.
https://doi.org/10.1182/blood-2019-125976
Published: 2019
Journal Articles

APR-246 Combined with Azacitidine (AZA) in TP53 Mutated Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML). a Phase 2 Study By the Groupe Francophone Des Myélodysplasies (GFM)

Thomas Cluzeau, MD PhD, Marie Sebert, MD, Ramy Rahmé, MD, Stefania Cuzzubbo, Anouk Walter-petrich, Jacqueline Lehmann che, Pierre Peterlin, Blandine Beve, Habiba Attalah, Fatiha Chermat, Elsa Miekoutima, Odile Beyne-Rauzy, Christian Recher, MD PhD, Aspasia Stamatoullas, MD, Lise Willems, MD, Emmanuel Raffoux, MD, Céline Berthon, MD PhD, Bruno Quesnel, Antoine Carpentier, David A Sallman, MD, Sylvie Chevret, MD PhD, Lionel Ades, MD PhD, Pierre Fenaux, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 677.
https://doi.org/10.1182/blood-2019-125579
Published: 2019
Journal Articles

Brentuximab Vedotin in First Refractory/Relapsed Classical Hodgkin Lymphoma Patients Treated By Chemotherapy (ICE) before Autologous Transplantation. Final Analysis of Phase II Study

Aspasia Stamatoullas, MD, Herv Ghesquieres, Lauriane Clement filliatre, MD, Philippe Quittet, MD, Franck Morschhauser, MD, Vincent Ribrag, MD, Veronique Edeline, MD, Pauline Brice
Journal: Blood
Blood (2019) 134 (Supplement_1): 132.
https://doi.org/10.1182/blood-2019-123925
Published: 2019
Journal Articles

Outcome of Patients with Hodgkin Lymphoma Treated with Brentuximab Vedotin for Relapse after Autologous Stem Cell Transplant: A Retrospective Analysis of the LWP-EBMT

Nikesh Dhiraj Chavda, MBBChir, Stephen Robinson, MBBS, PhD BSc, Ariane Boumendil, Irma Khvedelidze, Hervé Finel, Saad Akhtar, MD, M S Rauf, MD, Nadira Durakovic, MD, Radovan Vrhovac, MD PhD, Maurizio Musso, MD, Pauline Brice, Mutlu Arat, MD, Didier Blaise, MD PhD, Matthew P. Collin, MD PhD, Joanna Romejko-Jarosinska, MD PhD, Aspasia Stamatoullas, MD, Zubeyde Nur Ozkurt, MD, Tadeusz Robak, MD, Björn E Wahlin, MD PhD, Keith Wilson, FRCPath, MRCP, MBBS, Eleonora Alma, Rocco Pastano, Luca Castagna, MD, Ali Bazarbachi, MD PhD, Hervé Ghesquieres, MD PhD, Andrei Colita, MD PhD, Silvia Montoto, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4018.
https://doi.org/10.1182/blood-2019-131410
Published: 2019
Journal Articles

A Randomized Phase II Study of Azacitidine (AZA) Alone or with Lenalidomide (LEN), Valproic Acid (VPA) or Idarubicin (IDA) in Higher-Risk MDS: Gfm's 'pick a Winner' Trial

Lionel Ades, MD PhD, Agnès Guerci, Kamel Laribi, MD, Pierre Peterlin, Norbert Vey, MD PhD, Sylvain Thepot, MD, Stefan Wickenhauser, Hacene Zerazhi, Aspasia Stamatoullas, MD, Eric Wattel, MD PhD, Christian Recher, MD PhD, Andrea Toma, MD PhD, Krimo Bouabdallah, MD, Thorsten Braun, MD PhD, Odile Beyne-Rauzy, Berengere Gruson, MD, Stephane Cheze, Sophie Park, MD PhD, Thomas Cluzeau, MDPhD, Stanislas Nimubona, MD, Dominique Bordessoule, MD, Riad Benramdane, Bruno Quesnel, Shanti Ame, MD, Stephane De Botton, MD PhD, Fatiha Chermat, Julie Lejeune, Sylvie Chevret, MD PhD, Pierre Fenaux, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 467.
https://doi.org/10.1182/blood-2018-99-111756
Published: 2018
Journal Articles

Superiority of Allogenic Stem Cell Transplantation after Anti-PD1 Therapy over Anti-PD1 Monotherapy Alone in Relapse/Refractory Hodgkin Lymphoma: Real World Evidence from the French Early Access Program

Guillaume Manson, MD, Jean-Baptiste Mear, MD, Charles Herbaux, MD, Jean Marc Schiano de Collela, MD, Rene-Olivier Casasnovas, MD, Aspasia Stamatoullas, MD, Bénédicte Deau-Fisher, MD, Anna Schmitt, Georges Garnier, MD, Lysiane Molina, MD, Krimo Bouabdallah, MD, Marie-Pierre Moles, Herv Ghesquieres, Adrian Tempescul, MD, Remy Dulery, MD, Emmanuelle Nicolas-Virelizier, MD, Alain Jacques Delmer, MD, Cecile Borel, MD, Adrien Chauchet, MD, Laurent Dercle, MD, Pauline Brice, MD, Roch Houot, Pr, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1638.
https://doi.org/10.1182/blood-2018-99-110960
Published: 2018
Journal Articles

Prolonged remissions after anti-PD-1 discontinuation in patients with Hodgkin lymphoma

Clinical Trials & Observations
Guillaume Manson, Charles Herbaux, Pauline Brice, Krimo Bouabdallah, Aspasia Stamatoullas, Jean-Marc Schiano, Hervé Ghesquieres, Laurent Dercle, Roch Houot
Journal: Blood
Blood (2018) 131 (25): 2856–2859.
https://doi.org/10.1182/blood-2018-03-841262
Published: 2018
Journal Articles

Efficacy of Chemotherapy or Chemo-Anti-PD-1 Combination after Unsatisfactory Response of Anti-PD-1 Therapy for Relapsed and Refractory Hodgkin Lymphoma: A Retrospective Series from Lysa Centers

Cédric Rossi, MD, Julia Gilhodes, Marie Maerevoet, MD, Charles Herbaux, Pauline Brice, MD, Sylvain Garciaz, Cecile Borel, MD, Loic Ysebaert, MD PhD, Lucie Oberic, MD, Julien Lazarovici, MD, Bénédicte Deau-Fisher, MD, Jehan Dupuis, MD, Adrien Chauchet, Julie Abraham, MD, Fontanet Bijou, Aspasia Stamatoullas-Bastard, Jean Valère Malfuson, Camille Golfier, Camille Laurent, MDPhD, Salim Kanoun, MD, Thomas Filleron, PhD, Rene-Olivier Casasnovas, MD, Hervé Ghesquières, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 652.
https://doi.org/10.1182/blood.V130.Suppl_1.652.652
Published: 2017
Journal Articles

PET-Based Response after 2 Cycles of Brentuximab Vedotin in Combination with AVD for First-Line Treatment of Unfavorable Early-Stage Hodgkin Lymphoma: First Analysis of the Primary Endpoint of Breach, a Randomized Phase II Trial of Lysa-FIL-EORTC Intergroup

Luc-Matthieu Fornecker, Julien Lazarovici, MD, Igor Aurer, PhD, Rene-Olivier Casasnovas, MD, Anne-Claire Gac, Christophe Bonnet, MD PhD, Krimo Bouabdallah, MD, Aurore Perrot, MD, Lena Specht, Mohamed Touati, Jean Claude Eisenmann, Cecile Borel, MD, Aspasia Stamatoullas, MD, Emmanuelle Nicolas-Virelizier, MD, Laurent Pascal, Pieternella Lugtenburg, Monica Bellei, MSc, PhD, Alexandra traverse-Glehen, MD PhD, Christiane Copie, MDPhD, Martin Hutchings, MD PhD, Annibale Versari, Michel Meignan, Massimo Federico, Marc Andre, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 736.
https://doi.org/10.1182/blood.V130.Suppl_1.736.736
Published: 2017
Journal Articles

Sequential Lymphoma between Classical Hodgkin Lymphoma and Diffuse Large B Cell Lymphoma: Clinicopathological Characteristics and Outcome of 18 Patients from Lysa Center

Guillaume Aussedat, Hervé Ghesquières, MD PhD, Aspasia Stamatoullas, MD, Pierre Hirsch, MDPhD, Emmanuelle Nicolas-Virelizier, MD, Guillaume Cartron, Caroline Regny, Lionel Karlin, MD, Catherine Chassagne-Clément, MD, Violaine Safar, Nicolas Albin, MD, Antoine Deleuze, Alexis Lambour, Nicolas Daguindau, Christiane Copie, MDPhD, Richard Lemal, MD, Gilles Salles, MD PhD, Alexandra traverse-Glehen, MD PhD, Clementine Sarkozy, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4149.
https://doi.org/10.1182/blood.V130.Suppl_1.4149.4149
Published: 2017
Journal Articles

Patient and Physician Preferences for Front-Line Treatment of Advanced Stage Hodgkin Lymphoma in Germany, France and the United Kingdom

Paul Broeckelmann, Aspasia Stamatoullas, MD, Suzanne McMullen, Ben Wilson, MSc, Kerstin Mueller, MSc, MA, PhD, Sarah Goring, MSc, Erin Zagadailov, PharmD, MS, Ashish Gautam, PhD, Dirk Huebner, MD, Mehul Dalal, PhD, Tim M. Illidge, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4082.
https://doi.org/10.1182/blood.V130.Suppl_1.4082.4082
Published: 2017
Journal Articles

Combined Genotype Analysis of Tumor and Cell-Free DNA By Ultra-Deep Targeted Sequencing: Correlation with PET-Scan Imaging in a Prospective Cohort of Diffuse Large B-Cell Lymphoma Patients

Elodie Bohers, PhD, Pierre-Julien Viailly, Philippe Bertrand, Stephanie Becker, MD, Philippe Ruminy, PhD, Pascaline Etancelin, PharmD, Catherine Maingonnat, Jean-Michel Picquenot, MD, Anne Lise Menard, MD, Emilie Lemasle, MD, Nathalie Contentin, MD, Stéphane Leprêtre, MD, Pascal Lenain, MD, Aspasia Stamatoullas, MD, Helene Lanic, MD, Julie Libraire, Sandrine Vaudaux, Louis-Ferdinand Pepin, MD, Pierre Vera, Herve Tilly, Fabrice Jardin
Journal: Blood
Blood (2017) 130 (Supplement 1): 309.
https://doi.org/10.1182/blood.V130.Suppl_1.309.309
Published: 2017
Journal Articles

Additional Prognostic Impact of the Percentage of Erythroid Cells in the Bone Marrow of MDS Patients

Judith Neukirchen, MD, Heinz Tuechler, Matteo Giovanni Della Porta, MD, Pierre Fenaux, MD PhD, Ulrich Germing, MD, Agnès Guerci, Kathrin Nachtkamp, MD, Marianna Rossi, MD, Rosa Sapena, Wolfgang R. Sperr, MD, Corinna Strupp, MD, Aspasia Stamatoullas, MD, Peter Valent, MD, John M. Bennett, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4259.
https://doi.org/10.1182/blood.V130.Suppl_1.4259.4259
Published: 2017
Journal Articles

Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma

Clinical Trials & Observations
Reid W. Merryman, Haesook T. Kim, Pier Luigi Zinzani, Carmelo Carlo-Stella, Stephen M. Ansell, Miguel-Angel Perales, Abraham Avigdor, Ahmad S. Halwani, Roch Houot, Tony Marchand, Nathalie Dhedin, Willy Lescaut, Anne Thiebaut-Bertrand, Sylvie François, Aspasia Stamatoullas-Bastard, Pierre-Simon Rohrlich, Hélène Labussière Wallet, Luca Castagna, Armando Santoro, Veronika Bachanova, Scott C. Bresler, Amitabh Srivastava, Harim Kim, Emily Pesek, Marie Chammas, Carol Reynolds, Vincent T. Ho, Joseph H. Antin, Jerome Ritz, Robert J. Soiffer, Philippe Armand
Journal: Blood
Blood (2017) 129 (10): 1380–1388.
https://doi.org/10.1182/blood-2016-09-738385
Published: 2017
Includes: Supplemental data
Journal Articles

A Lysa Phase II Study of Oral JAK1/2 Inhibitor Ruxolitinib in Advanced Relapsed/Refractory (R/R) Hodgkin Lymphoma (HL)

Eric W Van Den Neste, MD PhD, Marc Andre, MD, Thomas Gastinne, MD, Aspasia Stamatoullas, MD, Corinne Haioun, MD PhD, Amine Belhabri, MD, Oumedaly Reman, MD, Olivier Casasnovas, MD, Herve Ghesquieres, MD PhD, Gregor Verhoef, MD PhD, Marie-José Claessen, Hélène A Poirel, Marie-Christine Copin, Romain Dubois, Peter Vandenberghe, MD PhD, Ioanna-Andrea Stoian, Anne Ségolène Cottereau, MD, Laurent Knoops, MD PhD, Franck Morschhauser
Journal: Blood
Blood (2016) 128 (22): 4160.
https://doi.org/10.1182/blood.V128.22.4160.4160
Published: 2016
Journal Articles

The Combination of High Expression of CD68-Positive Tumor-Associated Macrophages and PET2-Positivity Predicts Unfavorable Outcome in Patients with Classical Hodgkin Lymphoma Treated in the Lysa AHL2011 Study

Alexandra Traverse-Glehen, MD PhD, Diane Damotte, MD PhD, Peggy Dartigues, MD, Laurent Martin, MD PhD, Marie Parrens, MD PhD, Hervé Guesquieres, Clementine Sarkozy, Bénédicte Deau, MD, Reda Bouabdallah, MD, Sylvain Garciaz, MD, Michel Meignan, MD PhD, Véronique Edeline, MD, Salim Kanoun, MD, Alina Berriolo-Riedinger, MD, Pauline Brice, MD, Cedric Rossi, MD, Aspasia Stamatoullas, MD, Anne Sophie Veillard, Marc Andre, MD, Olivier Casasnovas, MD
Journal: Blood
Blood (2016) 128 (22): 1825.
https://doi.org/10.1182/blood.V128.22.1825.1825
Published: 2016